跳至主要内容
临床试验/NCT00815334
NCT00815334已完成不适用

Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance

Samsung Medical Center2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
2
主要终点
Cure rate

研究概览

简要总结

Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Who is aged 18 and greater
  • Who underwent endoscopic subureteral injection for vesicoureteral reflux

排除标准

  • Medical records of whom is not evaluabe

结局指标

主要结局

Cure rate

时间窗: 3, 12 months

次要结局

  • adverse events(3, 12 months)
  • predictive factor for cure(3, 12 months)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Efficacy of Endoscopic Subureteral Injection for... | 临床试验